Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal Cancer

NCT01290926 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT01290926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01290926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal Cancer
Lead sponsor
Jules Bordet Institute
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2011
Completion date
January 31, 2016
Enrollment
97 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer